BiotechTube

Afrezza + insulin degludec + Rapid-acting Insulin Analog + Basal Insulin

ApprovedCompleted
0 watching 0 views this week🔥 Hot
80
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Diabetes Mellitus, Type 1

Conditions

Diabetes Mellitus, Type 1

Trial Timeline

Jul 7, 2023 → Jun 24, 2024

NCT ID
NCT05904743

About Afrezza + insulin degludec + Rapid-acting Insulin Analog + Basal Insulin

Afrezza + insulin degludec + Rapid-acting Insulin Analog + Basal Insulin is a approved stage product being developed by MannKind Corp for Diabetes Mellitus, Type 1. The current trial status is completed. This product is registered under clinical trial identifier NCT05904743. Target conditions include Diabetes Mellitus, Type 1.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT05904743ApprovedCompleted

Competing Products

20 competing products in Diabetes Mellitus, Type 1

See all competitors
ProductCompanyStageHype Score
add-on pioglitazone + add-on sulphonylureaAMD BiotechApproved
77
MKP10241 + PlaceboMankind PharmaPhase 2
52
Daily injection of KBP/placebo for up to 28 daysEli LillyPhase 1
33
LY3209590 + Insulin DegludecEli LillyPhase 1
33
AC2993Eli LillyPhase 3
77
LY3209590 + PlaceboEli LillyPhase 1
33
Insulin Lispro Protamine Suspension + Insulin GlargineEli LillyPhase 3
77
LY2963016 + LantusEli LillyPhase 1
33
Empagliflozin + Other SGLT2 inhibitors + Other non-insulin GLDsEli LillyPre-clinical
23
Insulin Lispro Mix25 + Insulin Lispro Mix50Eli LillyApproved
85
Nasal Glucagon + Intramuscular GlucagonEli LillyPhase 3
77
Retatrutide + PlaceboEli LillyPhase 1
33
AG019 - Low Dose + Teplizumab + Placebo-AG019 + Placebo-Teplizumab + AG019 - High Dose + AG019 - High DosePrecigenPhase 1/2
36
LY4057996 SC + LY4057996 IV + Placebo SC + Placebo IV + Degludec SC + Lispro SC + Degludec IV + Pre-study basal insulin SCEli LillyPhase 1
33
Placebo + LinagliptinEli LillyPhase 3
77
Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Eli LillyApproved
85
teplizumab or placeboEli LillyPhase 1
33
LY2428757 + PlaceboEli LillyPhase 2
52
Insulin Efsitora Alfa + Insulin DegludecEli LillyPhase 3
77
LY900014 (SC) + LY900014 (IV)Eli LillyPhase 1
33

Other Products from MannKind Corp

Afrezza plus One Drop | PremiumApproved
80
Technosphere insulinApproved
80
Afrezza (insulin human) Inhalation Powder + insulin degludecApproved
80
Technosphere® Insulin with MedTone C Inhaler + Technosphere ®Insulin with Gen2 Inhaler + Insulin Aspart in combination with a basal insulinPhase 3
72
Technosphere® Insulin + Technosphere PowderPhase 3
72